Mainz Biomed to Commence Quarterly Reporting and Present at Equity Forum Spring Conference 2023 in Frankfurt, Germany

Mainz Biomed NV, a molecular genetics diagnostic company specializing in the early detection of cancer, announces the following activities in May.